(Q35116878)

6 August 2017

1 reference

title

Potential new therapeutics for Waldenstrom's macroglobulinemia (English)

1 reference

mitogen-activated protein (MAP) kinase, JNK

6 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720152

28 December 2023

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

28 December 2023

author name string

Frank Mercurio

4

1 reference

6 August 2017

Jerome B. Zeldis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720152

28 December 2023

Peter H. Schafer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720152

28 December 2023

Brydon L. Bennett

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720152

28 December 2023

David I. Stirling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12720152

28 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12720152

28 December 2023

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0093775403700931?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

https://api.elsevier.com/content/article/PII:S0093775403700931?httpAccept=text/plain

28 December 2023

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

28 December 2023

1 reference

6 August 2017

30

1 reference

6 August 2017

2

1 reference

6 August 2017

275-281

1 reference

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

6 August 2017

1

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

28 December 2023

4

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

28 December 2023

5

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha

28 December 2023

6

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity

28 December 2023

7

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

28 December 2023

8

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

28 December 2023

11

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

28 December 2023

12

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain

28 December 2023

14

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components

28 December 2023

15

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development

28 December 2023

16

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

The ubiquitin-proteasome pathway and pathogenesis of human diseases

28 December 2023

17

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Basic Medical Research Award. The ubiquitin system.

28 December 2023

18

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Themes and variations on ubiquitylation

28 December 2023

19

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase

28 December 2023

20

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

28 December 2023

21

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation

28 December 2023

22

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27

28 December 2023

23

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas

28 December 2023

24

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

28 December 2023

25

1 reference

https://api.crossref.org/works/10.1053/SONC.2003.50078

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference